Hairy cell leukaemia in a tertiary hospital in Southern Nigeria: 10 Year survey

Pakistan Journal of Medical Sciences

Volumn 23, Issue 2, 2007, Pages 259-263

  Omoti, C E ^a   Enosolease, M E ^a   Halim, N K D ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Hairy cell leukaemia; Nigeria

Indexed keywords

ALPHA INTERFERON; CLADRIBINE; CYTOSTATIC AGENT; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HAIRY CELL LEUKEMIA; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; INFECTION SENSITIVITY; MALE; NIGERIA; PANCYTOPENIA; PATHOLOGY; SPLENECTOMY; SPLENOMEGALY; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

EID: 34249721601     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jaiyesimi IA, Kantarjian HM, Estey EH. Advances in therapy for hairy cell leukaemia. A review. Cancer 1993;72(1):5-16.
2. Kraut EH. Clinical manifestations and infectious complications of hairy cell leukaemia. Best Pract Res Clin Haematol 2003;16(1):33-40.
3. Mey U, Strehl J, Gorschluter M, Ziske C, Glasmacher A, Pralle H, et al. Advances in the treatment of hairy cell leukaemia. Lancet Oncol 2003;4(2):86-94.
4. Lill MC, Golde DW. Treatment of hairy cell leukaemia. Blood Rev 1990;4(4):238-44.
5. Katayama I. Bone marrow in hairy cell leukaemia. Hematol Oncol Clin North Am 1988;2(4):585-602.
6. Glaspy JA, Jacobs AD, Golde DW. Evolving therapy of hairy cell leukaemia. Cancer 1987;59(3 Suppl):652-7.
7. Kristinsson SY, Vidarsson B, Agnarsson BA, Haraldsdottir V, Olafsson O, Johannesson GM, et al. Epidemiology of hairy cell leukaemia in Iceland. Hematol J 2002;3(3):145-7.
8. Au WY, Kwong YL, Ma SK, Mak YK, Wong KF, Lei KI, et al. Hairy cell leukaemia in Hong Kong Chinese: a 12 year retrospective survey. Hematol Oncol 2000;18(4):155-9.
9. Ruiz AGJ, Cantu ROG, Gomez AD, Cortes FG, Gongora BRA, Pizzuto J, et al. Hairy cell leukaemia is infrequent in Mexico and has a geographic distribution. Am J Hematol 1996;52(4):316-8.
10. Wing YA, Richard JK, Richard G, Nhu L, Randy DG, Joseph MC. Second malignancies in patients with hairy cell leukaemia in British Columbia: A 20-year Experience. Blood 1998;92(4):1160-4.
11. Clavel J, Hemon D, Mandereau L, Delemotte B, Severin F, Farming FG. Pesticide use in hairy cell leukaemia. Scand J Work Environ Health 1996;22(4):285-93.
12. Clavel J, Conso F, Limasset JC, Mandereau L, Roche P, Flandrin G, et al. Hairy cell leukaemia and occupational exposure to benzene. Occup Environ Health 1996;53(8):5339.
13. Clavel J, Mandereau L, Cordier S, Le Goaster C, Hemon D, Conso F, et al. Hairy cell leukaemia, occupation and smoking. Br J Haematol 1995;91(1):154-61.
14. Platanias LC, Ratain MJ. Hairy cell leukaemia: role of alpha interferon. Eur J Cancer 1991;27 Suppl 4:S 53-7.
15. Schmid M, Schrezenmeier H, Staib G, Porzsolt F. Evidence for a paracrine pathway of B cell stimulation in hairy cell leukaemia. Br J Haematol 1995;90(1):156-62.
16. Frassoldati A, Lamparelli T, Federico M, Annino L, Capnist G, Pagnucco, et al. Hairy cell leukaemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Leuk Lymphoma 1994;13(3-4):307-16.
17. Malhotra H, Advani SH, Gopal R, Saikia TK, Nadkarni KS, Pai VR, et al. Alpha-interferon in hairy cell leukaemia: an initial Indian experience. J Assoc Physicians India 1992;40(3):159-61.
18. Zinzani PL, Lauria F, Raspadori D, Rondelli D, Benfenati D, Pileri S, et al. Results in hairy cell leukaemia patients treated with alpha-IFN: predictive prognostic factors. Eur J Haematol 1992;49(3):133-7.